Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease. Issue 9 (15th December 2021)

Record Type:: Journal Article
Title:: Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease. Issue 9 (15th December 2021)
Main Title:: Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease
Authors:: Wellens, Judith
Edmans, Matthew
Obolski, Uri
McGregor, Colleen GC
Simmonds, Peter
Turner, Marc
Jarvis, Lisa
Skelly, Donal
Dunachie, Susanna
Barnes, Eleanor
Eyre, David W
Colombel, Jean-Frederic
Wong, Serre-Yu
Klenerman, Paul
Lindsay, James O
Satsangi, Jack
Thompson, Craig P
Abstract:
Is Part Of:: Gut. Volume 71:Issue 9(2022)
Journal:: Gut
Issue:: Volume 71:Issue 9(2022)
Issue Display:: Volume 71, Issue 9 (2022)
Year:: 2022
Volume:: 71
Issue:: 9
Issue Sort Value:: 2022-0071-0009-0000
Page Start:: 1919
Page End:: 1922
Publication Date:: 2021-12-15
Subjects:: IBD -- immune response -- infectious disease
Gastroenterology -- Periodicals
616.33
Journal URLs:: http://gut.bmjjournals.com ↗
http://www.bmj.com/archive ↗
DOI:: 10.1136/gutjnl-2021-326312 ↗
Languages:: English
ISSNs:: 0017-5749
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 23061.xml